Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy.

[1]  G. Filippatos,et al.  Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology , 2019, European journal of heart failure.

[2]  Stefan Neubauer,et al.  Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications , 2018, European heart journal cardiovascular Imaging.

[3]  E. Ashley,et al.  Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy , 2018, Circulation.

[4]  R. Swaminathan,et al.  Thirty‐Day Readmission Rates, Timing, Causes, and Costs after ST‐Segment–Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010–2014 , 2018, Journal of the American Heart Association.

[5]  T. Abraham,et al.  Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy , 2018, Journal of the American Heart Association.

[6]  Jeroen J. Bax,et al.  Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy , 2017, Circulation. Cardiovascular imaging.

[7]  Akshay S. Desai,et al.  Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. , 2017, JACC. Heart failure.

[8]  P. Elliott,et al.  Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement , 2017, Journal of cardiovascular medicine.

[9]  Jeroen J. Bax,et al.  Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation , 2017, Circulation. Arrhythmia and electrophysiology.

[10]  D. Theuns,et al.  Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy. , 2017, The American journal of cardiology.

[11]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  K. Hayashi,et al.  Right ventricular hypertrophy is associated with cardiovascular events in hypertrophic cardiomyopathy: evidence from study with magnetic resonance imaging. , 2015, The Canadian journal of cardiology.

[13]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[14]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[15]  Naoki Sato,et al.  The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.

[16]  Karina W. Davidson,et al.  Psychological Stress and 30-Day All-Cause Hospital Readmission in Acute Coronary Syndrome Patients: An Observational Cohort Study , 2014, PloS one.

[17]  M. Sheppard,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[18]  Y. Kim,et al.  Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  S. Schneeweiss,et al.  Repeated hospitalizations predict mortality in the community population with heart failure. , 2007, American heart journal.

[20]  W. Mckenna,et al.  Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy , 2005, Heart.

[21]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.